Janux Therapeutics, Inc. (JANX) Depreciation USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Janux Therapeutics, Inc. quarterly Depreciation history and growth rate from 2020 to 2024.
  • Janux Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $532K, a 17.4% increase year-over-year.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $532K +$79K +17.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.96M +$1.11M +132% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q1 2023 $453K +$372K +459% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $841K +$728K +644% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q1 2022 $81K +$72K +800% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $113K +$100K +769% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q1 2021 $9K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $13K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.